Kobayashi Score for IVIG Resistance Risk
Loading...
参考文献
- Yasutaka Kuniyoshi. Prediction Models for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Meta-analysis.. Pediatrics, 2023
- Wan-Ni Chiang. Evaluation of Formosa score and diagnostic sensitivity and specificity of four Asian risk scores for predicting intravenous immunoglobulin resistance in Kawasaki disease: a bivariate meta-analysis. Frontiers in Cardiovascular Medicine, 2023
- Mark Gorelik. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease.. Arthritis & rheumatology (Hoboken, N.J.), 2022
- I. Koné-Paut. Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin–Resistant Kawasaki Disease. Arthritis & Rheumatology, 2020
- H. Hamada. Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase . The Lancet, 2019
- B. McCrindle. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation, 2017
- Tohru Kobayashi. Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease. Circulation, 2006
- Reference - 10.1016/S2352-4642(21)00270-4